These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18794420)

  • 1. Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling.
    Fernandez-Ranvier GG; Weng J; Yeh RF; Khanafshar E; Suh I; Barker C; Duh QY; Clark OH; Kebebew E
    Arch Surg; 2008 Sep; 143(9):841-6; discussion 846. PubMed ID: 18794420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate diagnostic markers and tumor suppressor genes for adrenocortical carcinoma by expression profile of genes on chromosome 11q13.
    Fernandez-Ranvier GG; Weng J; Yeh RF; Shibru D; Khafnashar E; Chung KW; Hwang J; Duh QY; Clark OH; Kebebew E
    World J Surg; 2008 May; 32(5):873-81. PubMed ID: 18324346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy.
    Patterson EE; Holloway AK; Weng J; Fojo T; Kebebew E
    Cancer; 2011 Apr; 117(8):1630-9. PubMed ID: 21472710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors.
    Rechache NS; Wang Y; Stevenson HS; Killian JK; Edelman DC; Merino M; Zhang L; Nilubol N; Stratakis CA; Meltzer PS; Kebebew E
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E1004-13. PubMed ID: 22472567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors.
    Slater EP; Diehl SM; Langer P; Samans B; Ramaswamy A; Zielke A; Bartsch DK
    Eur J Endocrinol; 2006 Apr; 154(4):587-98. PubMed ID: 16556722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.
    Buishand FO; Liu-Chittenden Y; Fan Y; Tirosh A; Gara SK; Patel D; Meerzaman D; Kebebew E
    Surgery; 2020 Jan; 167(1):224-232. PubMed ID: 31522749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy.
    Koperski Ł; Kotlarek M; Świerniak M; Kolanowska M; Kubiak A; Górnicka B; Jażdżewski K; Wójcicka A
    Oncotarget; 2017 Jul; 8(30):49191-49200. PubMed ID: 28423361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis.
    Giordano TJ; Thomas DG; Kuick R; Lizyness M; Misek DE; Smith AL; Sanders D; Aljundi RT; Gauger PG; Thompson NW; Taylor JM; Hanash SM
    Am J Pathol; 2003 Feb; 162(2):521-31. PubMed ID: 12547710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum RARRES2 Is a Prognostic Marker in Patients With Adrenocortical Carcinoma.
    Liu-Chittenden Y; Patel D; Gaskins K; Giordano TJ; Assie G; Bertherat J; Kebebew E
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3345-52. PubMed ID: 27336360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours.
    Schmitz KJ; Helwig J; Bertram S; Sheu SY; Suttorp AC; Seggewiss J; Willscher E; Walz MK; Worm K; Schmid KW
    J Clin Pathol; 2011 Jun; 64(6):529-35. PubMed ID: 21471143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma.
    Gao Z; Man X; Li Z; Bi J; Liu X; Li Z; Zhu Y; Zhang Z; Kong C
    Oncol Rep; 2019 Apr; 41(4):2440-2452. PubMed ID: 30816525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression patterns associated with hyperfunctioning and non-hyperfunctioning phenotypes in adrenocortical adenomas.
    Velázquez-Fernández D; Caramuta S; Özata DM; Lu M; Höög A; Bäckdahl M; Larsson C; Lui WO; Zedenius J
    Eur J Endocrinol; 2014 Apr; 170(4):583-91. PubMed ID: 24446485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of differentially expressed microRNA in parathyroid tumors.
    Rahbari R; Holloway AK; He M; Khanafshar E; Clark OH; Kebebew E
    Ann Surg Oncol; 2011 Apr; 18(4):1158-65. PubMed ID: 21086055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors.
    Patel D; Boufraqech M; Jain M; Zhang L; He M; Gesuwan K; Gulati N; Nilubol N; Fojo T; Kebebew E
    Surgery; 2013 Dec; 154(6):1224-8; discussion 1229. PubMed ID: 24238045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidate genes associated with malignant pheochromocytomas by genome-wide expression profiling.
    Suh I; Shibru D; Eisenhofer G; Pacak K; Duh QY; Clark OH; Kebebew E
    Ann Surg; 2009 Dec; 250(6):983-90. PubMed ID: 19661783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Wnt and TGF-β pathway components and key adrenal transcription factors in adrenocortical tumors: association to carcinoma aggressiveness.
    Parviainen H; Schrade A; Kiiveri S; Prunskaite-Hyyryläinen R; Haglund C; Vainio S; Wilson DB; Arola J; Heikinheimo M
    Pathol Res Pract; 2013 Aug; 209(8):503-9. PubMed ID: 23866946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors.
    Fonseca AL; Kugelberg J; Starker LF; Scholl U; Choi M; Hellman P; Åkerström G; Westin G; Lifton RP; Björklund P; Carling T
    Genes Chromosomes Cancer; 2012 Oct; 51(10):949-60. PubMed ID: 22733721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
    Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
    Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel lipid metabolic biomarkers associated with poor adrenocortical carcinoma prognosis using integrated bioinformatics.
    Subramanian C; Cohen MS
    Surgery; 2022 Jan; 171(1):119-129. PubMed ID: 34353633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors.
    Doghman M; Arhatte M; Thibout H; Rodrigues G; De Moura J; Grosso S; West AN; Laurent M; Mas JC; Bongain A; Zambetti GP; Figueiredo BC; Auberger P; Martinerie C; Lalli E
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3253-60. PubMed ID: 17566092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.